Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. medimprove

MEDimprove

A novel online service to support self-care and responsible self-medication

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MEDimprove project word cloud

Explore the words cloud of the MEDimprove project. It provides you a very rough idea of what is the project "MEDimprove" about.

pharmacies    invested    convenient    fees    advertising    annual    patients    healthcare    environment    150    minor    see    platform    variables    worldwide    funds    counselling    morbidity    mortality    minimize    quality    revenues    services    companies    medicines    algorithm    clinical    stores    provides    medicate    health    integrating    2016    treat    professional    pharmaceutical    integrates    sale    buy    safe    2014    counter    self    nearly    8    provider    online    despite    usa    started    medicine    innovative    medication    life    suggests    gives    march    treatment    million    decision    people    15    cagr    founded    software    global    care    risks    context    responsible    easily    sales    created    supports    possibility    confidential    dermocosmetics    free    web    serfarma    market    euros    otc    personalized    shopping    medimprove    patient   

Project "MEDimprove" data sheet

The following table provides information about the project.

Coordinator		 SERFARMA LDA 

Organization address
address: RUA INSTITUTO PEDRO NUNES ED C RUA PEDRO NUNES
city: COIMBRA
postcode: 3030 199
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Portugal [PT]
 Project website http://www.serfarma.pt
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SERFARMA LDA PT (COIMBRA) coordinator 50˙000.00

Map

 Project objective

People often use over-the-counter (OTC) medicines to treat minor health problems and see these medicines as safe. Yet, like any other, OTC medicines present risks and can cause significant morbidity and mortality. To minimize these problems, the decision to self-medicate must take into account all patient's characteristics and relevant medicine information. Despite the risks, self-medication is an increasing practice worldwide and OTC medicines are easily available in stores and for online sale, without counselling from a healthcare provider, in EU and USA. In this global context, we created MEDimprove, a web platform for patients that supports responsible self-care and self-medication. The software is a clinical decision support system based on a complex algorithm that integrates all relevant patient and medicine variables and suggests the adequate safe treatment for each patient. It provides health information and personalized health counselling in a convenient, user-friendly and confidential environment. By integrating with online medicine stores, MEDimprove also gives the possibility to buy OTC medicines and other health products. For these stores, MEDimprove will increase sales by providing users with a professional and personalized counselling. Patients have free access to MEDimprove. Revenues come from: sales fees from pharmacies/medicine stores and advertising from pharmaceutical companies. We expect revenues of nearly 1.9 million euros in 3 years in a growing market of online OTC and dermocosmetics sales (which represent 15% of all online shopping and annual CAGR of the EU Market above 8%). We founded serFarma in 2014, providing innovative pharmaceutical services aiming to increase patients’ quality of life by using technology to promote the adequate use of medicines. We have invested over 150.000€ of own funds, and have started having revenues in March 2016.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDIMPROVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDIMPROVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More